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Centered on Molecules
The Vanderbilt University Center in
Molecular Toxicology is one of nineteen
NI EHS-supported
Environmental Health
Sciences Centers through- MoLECuLART
out the United States. Its Vandj.t primary purpose is to V l
enhance individual and
collaborative toxicology
programs at Vanderbilt and nationwide. As
scientists uncover how chemicals can cause
damage to people at the molecular level,
they will be able to develop techniques for
screening for individual genetic susceptibil-
ity to environmental toxins and for effec-
tive preventive measures to protect human
health. A hallmark ofthe Vanderbilt center
is its interdisciplinary approach to under-
standing toxicological problems from the
biochemical perspective and investigating
questions related to toxicity at the molecu-
lar level.
The Vanderbilt School ofMedicine has
been in the vanguard ofresearch on cancer-
causing substances since the Division of
Toxicology was founded in 1967 in the
Department of Biochemistry under the
direction ofthe late Frank R. Blood. At its
inception, the mission of the Division of
Toxicology was the coordination of
research and teaching related to harmful
substances in foods such as chemical addi-
tives, naturally occurring toxins, and
residues from agricultural pesticides and
packaging materials. The division's success
led to the establishment of the Vanderbilt
Center in Environmental Toxicology
under the auspices of an NIH
Environmental Health Sciences grant in
1969. Over the years, the program has
become increasingly interdisciplinary, with
faculty in the departments ofbiochemistry,
cell biology, chemistry, medicine, patholo-
gy, and pharmacology. Research emphasis
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Center of the center. Most of the Center in Molecular Toxicology's core groups are located in the
Medical Research Building 1, on the campus ofVanderbilt University.
has broadened to encompass endogenous
chemicals and synergistic deleterious effects
resulting from combinations of different
chemicals in the body, all of which may
give rise to mutations and play a role in
activating oncogenes and inactivating
tumor suppressor genes. The name was
changed to the Center in Molecular
Toxicology in 1984 to reflect increasing
specialization in areas of toxicology that
use molecular methodologies to elucidate
physiological and genetic changes due to
environmental and biogenic toxins.
Structure
The Center in Molecular Toxicology is
organized into administrative cores, service
cores, research cores, and an outreach pro-
gram. The administrative cores are respon-
sible for a variety oftasks including coordi-
nating the toxicology seminar series and an
annual visit by the
_ External Advisory Group,
_ processing applications,
_ writing manuscripts and
grants and managing com-
puter databases. The edito-
rial office of the American
Chemical Society's journal,
Chemical Research in
Toxicology, is also located
at the center.
The service cores pro-
vide a full range of tech-
' -g nological support and
facilities necessary for
molecular experimenta-
tion including NMR
spectrometry, mass spec-
trometry, molecular biology, cell biology,
and protein chemistry. The NMR and
mass spectrometry facilities include state-
of-the-art instrumentation for high-resolu-
tion analysis ofbiological macromolecules,
which are critical in analytical chemistry
for characterization ofoligonucleotides and
natural and synthetic molecules. The cell
biology core provides human tissue and
cell cultures, as well as monoclonal anti-
bodies for biological studies. The protein
chemistry core provides amino acid analy-
sis and sequence determination of pep-
tides, and the molecular biology core pro-
vides recombinant DNA technologies such
as automated DNA synthesis and amplifi-
cation.
There are seven core areas of research:
enzymatic oxidation and conjugation,
oxidative damage, DNA damage and
mutagenesis, regulation ofgene expression,
analytic method development, neurotoxi-
cology, and clinical toxicology.
Enzyme Bioactivation ofToxic
Chemicals
The proteins, lipids, and sugars that make
up a major part of foods, as well as other
chemicals entering the body such as drugs
or xenobiotics, are broken down by
enzymes into smaller molecules before cells
either use or eliminate them. Cells oxidize
molecules through a series ofenzyme-medi-
ated reactions. Different environmental
chemicals interact with enzymes in the
body in various ways to alter normal bio-
logical processes. Certain enzymes in the
liver catalyze detoxication reactions in
which water-insoluble drugs and xenobi-
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otics, which would oth-
erwise cause cellular
damage by becoming
permanently attached
to cell membranes or
DNA, are made water-
soluble and removed
from the bodyby urine.
Center Director F.
Peter Guengerich has
pioneered investigation
of the enzyme cyto-
chrome P450, a primary
catalyst involved in the
oxidation of drugs,
steroid hormones, and
carcinogens. According
to Guengerich, "There Michael R.Waterma
are over forty different
kinds ofP450 in the human body. The ones
I am most interested in are the ones that act
on chemicals that are not normally found in
the human body (xenobiotics). We are trying
to understand how enzymes detoxify drugs
and carcinogens and how these same
enzymes can also make them more active."
A major contribution to this under-
standing was Guengerich's characterization
of how P450 converts aflatoxin a natural
chemical produced by a fungus that grows
on rice, peanuts, and corn-into a potent
carcinogen when ingested. Human popula-
tions in Africa and China, countries that
lack adequate inspection of agricultural
products, have unusually high rates ofliver
cancer caused by aflatoxin. Guengerich and
colleagues at Vanderbilt identified a particu-
lar P450 enzyme involved in aflatoxin
bioactivation. Thomas Harris, associate
director ofthe center, synthesized the active
an
Lawrence J. Marnett
form of aflatoxin, a
E potent epoxide that
sticks to DNA, and
_ has done most of the
center s chemical ex-
perimentation on this
molecule.
Guengerich is
currently collaborat-
n!lbd | t!g ag ing with scientists at
Johns Hopkins Uni-
versity to investigate
the role of a newly
discovered cyto-
- .= chrome that is found
in high concentra-
tions in the breast,
uterus, ovaries, and
prostate gland, and
that may play a role in cancers in the
human reproductive system. An important
objective ofthis research is to delineate the
steps in initiation of P450 carcinogenic
activity in order to design
effective drug therapies that
can be used to prevent
enzyme-mediated cancers.
Working with Michael
R. Waterman, professor and
chairman of biochemistry,
Guengerich has genetically
engineered E. coli bacteria
with human P450 genes that
express high levels of the
newly discovered enzymes. P
Human cytochrome P450s
have also been engineered
directly into the Ames
Salmonella tester strain for
genotoxicity, which has prac-
tical application for screening Thomas Harris
mutagenic effects ofchemicals
activated by human enzymes. The bacterial
expression system will also be avaluable tool
in site-directed mutagenesis studies.
DNA Damage from Endogenous
Chemicals
Research in the A.B. Hancock, Jr.,
Memorial Laboratory for Cancer Research,
directed by Lawrence J. Marnett, has
shown considerable DNA damage may be
caused by endogenous chemicals produced
during the body's normal metabolic
processes. Marnett says, "The scientific
community originally thought that it was
only chemicals in the environment [that
caused damage]. We now know that our
own bodies damage our DNA through nor-
mal processes." Marnett is particularly
interested in enzymes that catalyze the con-
version of polyunsaturated fatty acids to
bioactive lipids such as prostaglandin.
These fatty-acid derivatives bind to differ-
ent cell-surface receptors and have various
biological effects including smooth muscle
contraction and inflammation. DNA
adducts can be formed from lipid oxidation
products. Marnett is investigating the bio-
logical consequences of the adherence of
endogenous chemicals produced by lipid
biosynthesis to DNA, and how such chem-
icals act as internal mediators to initiate
mutations and tumors in human tissues.
Certain byproducts oflipid oxidation are of
particular concern because they have been
implicated in tumor metastasis. Approaches
to studying the causes and effects of DNA
damage being used in Marnett's lab include
measuring the amount ofdamage to DNA,
and creating synthetic DNA molecules that
have been damaged in various ways to use
as models. "We try to introduce the dam-
age to a specific site and then observe the
effects of the damage," Marnett says. The
findings of basic research promise to have
practical benefits to health care by improv-
ing the ability to assess people at risk for
different types of cancer. "The biggest
impact our work can have is in human risk
assessment," Marnett predicts. "We will
have a better concept of what is causing
cancer in people, and, therefore, will soon
be better able to determine who is at risk
for certain types ofcancer.
Aspirin-Enzyme Link
Many cancers are caused by oxidative
stress. A recent discovery revealed that
aspirin and other nonsteroidal anti-inflam-
matory drugs (NSAIDs) function by
blocking enzymes involved in the lipid oxi-
dation process to prevent formation of
harmful, biologically active intermediates.
Comparing cancerous tissue and healthy
tissue from 28 patients who underwent
surgery for colon cancer, Raymond N.
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Timothy Meredith
DuBois, an associate professor ofmedicine
and cell biology, found unusually high lev-
els of one such enzyme, cyclooxygenase-2
(COX-2), in cancerous colon tissue,
whereas levels in healthy tissue were very
low or undetectable. COX-2 leads to pro-
duction of prostaglandin and other bio-
genic chemicals linked to cancer. It has
been shown that arthritis patients who take
NSAIDs regularly have a 50% reduction in
risk for developing colon cancer. Colo-
rectal cancer is one ofthe leading causes of
cancer mortality; approximately 150,000
people are diagnosed with colon cancer
and over 50,000 die from the disease each
year. DuBois is investigating how aspirin
inhibits COX-2 activity and thereby
reduces cancer risk. Understanding the
enzyme blocking mechanism can lead to
better diagnostic and screening strategies,
as well as development of highly specific,
targeted therapies for the prevention of
intestinal tumors.
Outreach
An important part of the center's outreach
program is the Clinical Toxicology Center,
which indudes the Middle Tennessee Poison
Center (MTPC). The MTPC comprises a
dinical toxicology admitng service and out-
patient clinic service, an occupational and
environmental medicine section, and analyti-
cal toxicology laboratories. The dinical toxi-
cology admitting and outpatient clinic is
staffed by faculty members with backgrounds
ininternal, occupational, andemergencymed-
icine. It is the only such service in Tennessee
andoneofthree nationwide. "The addition of
clinical toxicology at Vanderbilt is a tremen-
dous opportunity,"
said Guengerich ofthe
MTPC. "It should be
one of the premier
programs ofits type in
the nation and should
complement our exist-
ingstrengths in molec-
ularprograms."
The MTPC pro-
gram, directed by the
Center in Molecular
T o x i c o I o g y s
Timothy Meredith,
serves 57 counties in
Tennessee, covering
a population of
approximately 3 mil-
lion. The MTPC is
now extending the
original primary service of prevention and
management of poisoning due to house-
hold chemicals and drugs to include expo-
sure to environmental chemicals. The
MTPC is establishing an environmental
chemicals "hotline" to answer questions
about adverse health effects from exposure
to environmental chemicals, and is devel-
oping an interactive database focused on
environmental chemicals and health-relat-
ed problems. The database will be accessi-
ble on-line via the World Wide Web at
http://www.toxicology.mc.vanderbilt.edu.
Training in toxicology at the center
extends from undergraduate to graduate,
postdoctoral, and medical students. In
addition to formal courses and seminars on
toxicology, students are offered the oppor-
tunity to participate in ongoing research
projects to gain skills essential to investiga-
tions in molecular toxicology and clinical
applications. Two monthly seminars are
conducted by center faculty and by outside
scientists ofnational renown.
Reflecting on its past historyand looking
toward the future ofthe Center in Molecul-
ar Toxicology, Guengerich says, "Over the
Raymond N. DuBois
Raymond N. DuBois
years, our center has
been able to develop
by emphasizing high
quality science, and
we've been able to
assemble an outstand-
ing group of individu-
als. There is consider-
able strength in chem-
istry and carcinogene-
sis, and some of the
new directions such as
neurotoxicology and
gene regulation should
enhance our overall
scientific program." As
scientists like those at
the center carry on
their work, they are
charting new courses
for delivering improved health care, enhanc-
ing human risk assessment, and solving
modern environmental health problems.
MaryEubanks
Visit the Center in MolecularToxicology on the Webt
http:flwww.txicoloy.mc.vandPorl. dnI d
The Center provides an environment for research efforts in molecular toxicology by i andEffihlated
biochemistry, cell biology, chemistry, medicine, pathology, and pha=mcalo#.
The site provides information on the center's research and service cores, study andtraining&Cetrs andialiates,
community outreach and education, and a calendar ofevents.
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Wilson Named Deputy
Director
On September 1, Samuel H.
Wilson, an expert in the fields of
environmental toxicology and
genetic enzymology, will join the
NIEHS as its new deputy direc-
tor. Wilson will be responsible for
helping Director Kenneth Olden
administer the NIEHS, which
employs over 850 people and has
an annual budget and pass-
through funds of approximately
a $365 million. Wilson said that he sees the position as an opportu-
nity to "stimulate and foster outstanding research nationally in
environmental health science and to make enhanced use of the
research strengths [at the institute]."
Wilson emphasized that increased partnership and interaction
between the academic community and industry would be neces-
sary to achieve these goals. Increased cooperation will allow
research to progress more efficiently, Wilson said, and will be
beneficial to both sectors. "These relationships can be facilitated
byNIEHS," he said.
Wilson also said he would like to see the NIEHS place more
emphasis on the development of new research technologies. "We
need to take advantage of new advances in molecular genetics to
help us better understand the impact ofenvironmental exposure on
health," Wilson said. As an example ofhowsuch technologies could
advance the field ofenvironmental health, Wilson cited the use of
genetically engineered bacteria and animals as sentinels for detect-
ingtoxicants.
A world-recognized authority on DNA polymerases, Wilson
brings with him extensive knowledge and experience in genetics
and toxicology. Currently at the University of Texas Medical
Branch at Galveston, Wilson is the founding director of the
Sealy Center for Molecular Science and holds the Mary Gibbs
Jones Distinguished Chair in Environmental Toxicology. He
also serves as director of the Centennial Center for
Environmental Toxicology and is a professor in the Department
ofHuman Biological Chemistry and Genetics.
Before his University of Texas appointment, Wilson was
chief of the Nucleic Acid Enzymology Section at the National
Cancer Institute's Laboratory of Biochemistry in Bethesda,
Maryland. His career with NCI, a sister institute ofthe NIEHS,
began in 1970. Since that time, Wilson's pioneering research in
the field ofgenetic enzymes, which are responsible for replication
and repair ofgenomic DNA, has led to a much greater under-
standing ofhow these enzymes function. His workcould eventu-
ally enable scientists to design drugs that control replication of
cancer cells orviral replication within HIV-infected cells.
Wilson received his M.D. from Harvard Medical School in
1968. He received postdoctoral training at Dartmouth Medical
School and the National Institutes ofHealth. "With the appoint-
ment ofDr. Wilson, the institute is gaining the benefit ofan out-
standing researcher and science administrator," Olden said.
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